Accentia Biopharmace (ABPI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ABPI | AMGN | VRTX | REGN | BMY |
| Company | Accentia Biopharmace | Amgen Inc | Vertex Pharmaceutic | Regeneron Pharmaceuticals | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | OTC US | NASDAQ | NASDAQ | NASDAQ | NYSE |
| Open | 0.0001 | 314.63 | 434.59 | 978.27 | 44.47 |
| High | 0.0001 | 315.27 | 438.51 | 978.30 | 44.53 |
| Low | 0.0001 | 310.76 | 432.22 | 971.78 | 43.68 |
| Last | 0.0001 | 314.29 | 438.10 | 974.29 | 43.92 |
| Change | unch | -2.50 | +0.61 | -3.92 | -0.63 |
| % Change | unch | -0.79% | +0.14% | -0.40% | -1.41% |
| Volume | 400 | 878,490 | 407,903 | 94,981 | 6,578,681 |
| 20-Day Average Volume | 25,130 | 2,905,278 | 1,077,406 | 445,769 | 14,225,708 |
| Previous Close | 0.0001 | 316.79 | 437.49 | 978.21 | 44.55 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.0001 | 291.38 | 409.68 | 935.38 | 45.28 |
| 20-Day Raw Stochastic | 0.00% | 86.81% | 94.80% | 88.27% | 10.76% |
| 20-Day Relative Strength | 34.07% | 65.24% | 68.28% | 60.37% | 33.78% |
| Weighted Alpha | -45.13 | +40.05 | +29.70 | +29.63 | -34.33 |
| Today's Opinion | N/A | 72% Buy | 72% Buy | 72% Buy | 100% Sell |
| Previous Opinion | N/A | 72% Buy | 56% Buy | 72% Buy | 100% Sell |
| Last Month's Opinion | N/A | 56% Sell | 8% Buy | 24% Buy | 56% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | unch since 12/30/15 | +0.50% since 05/09/24 | +4.24% since 05/09/24 | +0.82% since 05/09/24 | -1.65% since 05/09/24 |
| Low | 0.0001 on 01/06/16 | 307.06 on 05/13/24 | 417.50 on 05/10/24 | 966.34 on 05/15/24 | 43.68 on 05/16/24 |
| High | 0.0001 on 01/06/16 | 321.44 on 05/15/24 | 439.26 on 05/15/24 | 988.96 on 05/15/24 | 45.72 on 05/14/24 |
| 1-Month | |||||
| %Chg | unch since 11/24/15 | +18.37% since 04/16/24 | +10.81% since 04/16/24 | +9.15% since 04/16/24 | -8.82% since 04/16/24 |
| Low | 0.0001 on 01/06/16 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 875.22 on 04/26/24 | 43.33 on 05/02/24 |
| High | 0.0010 on 12/16/15 | 322.60 on 05/03/24 | 439.26 on 05/15/24 | 988.96 on 05/15/24 | 49.56 on 04/22/24 |
| 3-Month | |||||
| %Chg | -97.22% since 10/05/15 | +10.83% since 02/16/24 | +3.45% since 02/16/24 | +2.94% since 02/16/24 | -11.75% since 02/16/24 |
| Low | 0.0001 on 01/06/16 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 875.22 on 04/26/24 | 43.33 on 05/02/24 |
| High | 0.0050 on 11/02/15 | 322.60 on 05/03/24 | 439.26 on 05/15/24 | 998.33 on 02/28/24 | 55.03 on 03/13/24 |
| 6-Month | |||||
| %Chg | -97.96% since 07/06/15 | +16.89% since 11/16/23 | +27.34% since 11/16/23 | +22.52% since 11/16/23 | -13.45% since 11/16/23 |
| Low | 0.0001 on 01/06/16 | 260.52 on 11/21/23 | 342.64 on 11/17/23 | 792.57 on 11/28/23 | 43.33 on 05/02/24 |
| High | 0.0057 on 07/13/15 | 329.72 on 02/05/24 | 448.40 on 01/30/24 | 998.33 on 02/28/24 | 55.03 on 03/13/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 10 | 171,144,224 | 112,895,608 | 107,785,040 | 90,307,296 |
| Shares Outstanding, K | 89,760 | 536,435 | 258,053 | 110,186 | 2,027,100 |
| Annual Sales | 4,050,000 | 28,190,000,000 | 9,869,200,000 | 13,117,200,000 | 45,006,000,000 |
| Annual Net Income | -4,320,000 | 6,717,000,000 | 3,619,600,000 | 3,953,600,000 | 8,025,000,000 |
| Last Quarter Sales | N/A | 7,447,000,000 | 2,690,600,000 | 3,145,000,000 | 11,865,000,000 |
| Last Quarter Net Income | N/A | -113,000,000 | 1,099,600,000 | 722,000,000 | -11,911,000,000 |
| 60-Month Beta | -0.47 | 0.60 | 0.39 | 0.17 | 0.45 |
| Per-Share Information | |||||
| Most Recent Earnings | N/A | 3.96 on 05/02/24 | 4.76 on 05/06/24 | 9.55 on 05/02/24 | -4.40 on 04/25/24 |
| Latest Earnings Date | 06/26/14 | 05/02/24 | 05/06/24 | 05/02/24 | 04/25/24 |
| Most Recent Dividend | N/A | 2.250 on 05/16/24 | N/A | N/A | 0.600 on 04/04/24 |
| Next Ex-Dividends Date | N/A | 05/16/24 | N/A | N/A | 04/04/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 16.72 | 28.46 | 26.53 | 42.58 |